{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:12Z","timestamp":1788782892673,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82161138021"],"award-info":[{"award-number":["82161138021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["468853597"],"award-info":[{"award-number":["468853597"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.schres.2026.06.022","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:22:02Z","timestamp":1783005722000},"page":"43-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quality evaluation of randomized controlled trials of antipsychotic drugs for schizophrenia published in Chinese journals"],"prefix":"10.1016","volume":"296","author":[{"given":"Yu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Siafis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bighelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Priller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schneider-Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.schres.2026.06.022_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12874-020-01076-x","article-title":"Quality of evidence in a post-soviet country: evaluation of methodological quality of controlled clinical trials published in national journals from Uzbekistan","volume":"20","author":"Aripov","year":"2020","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.schres.2026.06.022_bb0010","article-title":"Tackling research misconduct","volume":"386","author":"Bouter","year":"2024","journal-title":"BMJ (Clinical Research ed.)"},{"key":"10.1016\/j.schres.2026.06.022_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13584-016-0061-z","article-title":"International publication trends and collaboration performance of China in healthcare science and services research","volume":"5","author":"Chen","year":"2016","journal-title":"Isr. J. Health Policy Res."},{"issue":"5\u20136","key":"10.1016\/j.schres.2026.06.022_bb0025","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/08989621.2013.822248","article-title":"Understanding research misconduct: a comparative analysis of 120 cases of professional wrongdoing","volume":"20","author":"DuBois","year":"2013","journal-title":"Account. Res."},{"key":"10.1016\/j.schres.2026.06.022_bb0030","author":"eEML - Electronic Essential Medicines List"},{"issue":"4","key":"10.1016\/j.schres.2026.06.022_bb0035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1248\/yakushi.17-00181-1","article-title":"Research misconduct in Japan and how it is covered by the media","volume":"138","author":"Enoki","year":"2018","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.schres.2026.06.022_bb0040","series-title":"Publication activity in the science citation index expanded (SCIE) database in the context of Chinese science and technology policy from 1977 to 2012","author":"Fu","year":"2013"},{"issue":"2","key":"10.1016\/j.schres.2026.06.022_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/picr.PICR_60_18","article-title":"The assessment of the quality of randomized controlled trials published in Indian medical journals","volume":"10","author":"Goenka","year":"2019","journal-title":"Perspect. Clin. Res."},{"key":"10.1016\/j.schres.2026.06.022_bb3000","series-title":"Association of Reliability and Methodological Quality With Publication Features: Appraisal of Randomized Clinical Trial of Antipsychotic Drugs for Schizophrenia in China","author":"Guan","year":"2026"},{"issue":"9","key":"10.1016\/j.schres.2026.06.022_bb0050","first-page":"7","article-title":"A survey on the reporting quality of clinical randomized controlled trials in 5 Chinese psychiatric journals from 2016 to 2020","volume":"22","author":"Hai","year":"2022","journal-title":"Chinese Journal of Evidence-based Medcine"},{"issue":"1","key":"10.1016\/j.schres.2026.06.022_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhydrol.2009.01.040","article-title":"Enhancing the effectiveness of prewhitening in trend analysis of hydrologic data","volume":"368","author":"Hamed","year":"2009","journal-title":"J. Hydrol."},{"key":"10.1016\/j.schres.2026.06.022_bb0060","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5","author":"Higgins JPT","year":"2024"},{"issue":"5","key":"10.1016\/j.schres.2026.06.022_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.respol.2020.103983","article-title":"Public funding and the ascent of Chinese science: evidence from the National Natural Science Foundation of China","volume":"49","author":"Hu","year":"2020","journal-title":"Res. Policy"},{"issue":"10202","key":"10.1016\/j.schres.2026.06.022_bb0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.schres.2026.06.022_bb0075","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.06.022_bb0080","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/JCP.0b013e31820f932a","article-title":"What can we learn from Chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies","volume":"31","author":"Koesters","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.schres.2026.06.022_bb0085","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S2215-0366(22)00304-2","article-title":"The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis","volume":"9","author":"Leucht","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.06.022_bb0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1556264620927628","article-title":"Defining and handling research misconduct: a comparison between Chinese and European institutional policies","volume":"15","author":"Li","year":"2020","journal-title":"J. Empir. Res. Hum. Res. Ethics"},{"key":"10.1016\/j.schres.2026.06.022_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2020.11.010","article-title":"Sequential multiple-assignment randomized trials to compare antipsychotic treatments (SMART-CAT) in first-episode schizophrenia patients: rationale and trial design","volume":"230","author":"Li","year":"2021","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.schres.2026.06.022_bb0100","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.schres.2026.06.022_bb0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/schbul\/sbr140","article-title":"Content and quality of 10,000 controlled trials in schizophrenia over 60 years","volume":"39","author":"Miyar","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.06.022_bb0110","article-title":"Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment","volume":"346","author":"Panagiotou","year":"2013","journal-title":"BMJ (Clinical Research ed.)"},{"key":"10.1016\/j.schres.2026.06.022_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2019.100441","article-title":"Systematic review on the quality of randomized controlled trials from Saudi Arabia","volume":"16","author":"Rajab","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"issue":"10327","key":"10.1016\/j.schres.2026.06.022_bb0120","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(21)01997-8","article-title":"Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis","volume":"399","author":"Schneider-Thoma","year":"2022","journal-title":"Lancet"},{"issue":"10531","key":"10.1016\/j.schres.2026.06.022_bb3005","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0140-6736(25)02365-7","article-title":"Comparative efficacy and tolerability of antidopaminergic and muscarinic antipsychotics for acute schizophrenia: a network meta-analysis of randomised controlled trials indexed in international English and Chinese databases","volume":"407","author":"Schneider-Thoma","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2026.06.022_bb0125","article-title":"A bibliometric analysis of international publications and citation trends of articles in mental health produced by Chinese institutions in mainland China (1990-2019)","volume":"8","author":"Severino","year":"2021","journal-title":"Glob Ment Health (Camb)"},{"issue":"2","key":"10.1016\/j.schres.2026.06.022_bb0130","doi-asserted-by":"crossref","DOI":"10.2174\/1574887118666230221114201","article-title":"The deficits of the methodological and reporting quality of randomized controlled trials in the field of prosthetics and orthotics in Iran: a systematic review","volume":"18","author":"Shahabi","year":"2023","journal-title":"Rev. Recent Clin. Trials"},{"issue":"10","key":"10.1016\/j.schres.2026.06.022_bb0135","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","article-title":"A consensus-based checklist for reporting of survey studies (CROSS)","volume":"36","author":"Sharma","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.schres.2026.06.022_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-015-0469-2","article-title":"\u2018Predatory\u2019 open access: a longitudinal study of article volumes and market characteristics","volume":"13","author":"Shen","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.schres.2026.06.022_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2024.111302","article-title":"Misleading presentations in functional food trials led by contract research organizations were frequently observed in Japan: meta-epidemiological study","volume":"169","author":"Someko","year":"2024","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.schres.2026.06.022_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0970-258X.253165","article-title":"An assessment of the compliance of randomized controlled trials published in two high impact journals with the CONSORT statement","volume":"31","author":"Susvirkar","year":"2018","journal-title":"Natl Med. J. India"},{"issue":"1","key":"10.1016\/j.schres.2026.06.022_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-018-0554-2","article-title":"Quality of randomized controlled trials of new generation antidepressants and antipsychotics identified in the China National Knowledge Infrastructure (CNKI): a literature and telephone interview study","volume":"18","author":"Tong","year":"2018","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.schres.2026.06.022_bb0160","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/d41586-023-02299-w","article-title":"Audio long read: medicine is plagued by untrustworthy clinical trials. How many studies are faked or flawed?","volume":"619","author":"Van Noorden","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.schres.2026.06.022_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001162","article-title":"The methodological quality of 176,620 randomized controlled trials published between 1966 and 2018 reveals a positive trend but also an urgent need for improvement","volume":"19","author":"Vinkers","year":"2021","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.schres.2026.06.022_bb0170","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s11948-018-0040-6","article-title":"Retracted publications in the biomedical literature from open access journals","volume":"25","author":"Wang","year":"2019","journal-title":"Sci. Eng. Ethics"},{"issue":"1","key":"10.1016\/j.schres.2026.06.022_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-10-46","article-title":"Randomized trials published in some Chinese journals: how many are randomized?","volume":"10","author":"Wu","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.schres.2026.06.022_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082068","article-title":"Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY study I): retrospective cohort study","volume":"389","author":"Xu","year":"2025","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.schres.2026.06.022_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037262","article-title":"Characteristics and trends of clinical studies primarily sponsored by China in WHO primary registries between 2009 and 2018: a cross-sectional survey","volume":"10","author":"Xu","year":"2020","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.schres.2026.06.022_bb0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1623\/hysj.49.1.21.53996","article-title":"A comparison of the power of the t test, Mann-Kendall and bootstrap tests for trend detection","volume":"49","author":"Yue","year":"2004","journal-title":"Hydrol. Sci. J."},{"key":"10.1016\/j.schres.2026.06.022_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-9-22","article-title":"An assessment of the quality of randomised controlled trials conducted in China","volume":"9","author":"Zhang","year":"2008","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.schres.2026.06.022_bb0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jclinepi.2010.02.010","article-title":"Are randomized trials conducted in China or India biased? A comparative empirical analysis","volume":"64","author":"Zhang","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"10002","key":"10.1016\/j.schres.2026.06.022_bb0205","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(15)00341-4","article-title":"Cultivating and investing in clinical research in China","volume":"386","author":"Zhang","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.schres.2026.06.022_bb0210","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1176\/appi.ajp.20250111","article-title":"Efficacy and tolerability of seven antipsychotic drugs in acutely ill patients with schizophrenia: a randomized, multicenter, assessor-blinded trial","volume":"183","author":"Zhao","year":"2025","journal-title":"Am. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:18:12Z","timestamp":1788779892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426002057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S0920996426002057"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.06.022","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality evaluation of randomized controlled trials of antipsychotic drugs for schizophrenia published in Chinese journals","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}